Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Brennenstuhl, Heiko [VerfasserIn]   i
 Kohlmüller, Dirk [VerfasserIn]   i
 Gramer, Gwendolyn [VerfasserIn]   i
 Garbade, Sven [VerfasserIn]   i
 Syrbe, Steffen [VerfasserIn]   i
 Feyh, Patrik [VerfasserIn]   i
 Kölker, Stefan [VerfasserIn]   i
 Okun, Jürgen G. [VerfasserIn]   i
 Hoffmann, Georg F. [VerfasserIn]   i
 Opladen, Thomas [VerfasserIn]   i
Titel:High throughput newborn screening for aromatic ʟ-amino-acid decarboxylase deficiency by analysis of concentrations of 3-O-methyldopa from dried blood spots
Verf.angabe:Heiko Brennenstuhl, Dirk Kohlmüller, Gwendolyn Gramer, Sven F. Garbade, Steffen Syrbe, Patrik Feyh, Stefan Kölker, Jürgen G. Okun, Georg F. Hoffmann, Thomas Opladen
Jahr:2020
Jahr des Originals:2019
Umfang:9 S.
Fussnoten:First published: 18 December 2019 ; Gesehen am 04.06.2020
Titel Quelle:Enthalten in: Journal of inherited metabolic disease
Ort Quelle:Hoboken, NJ : Wiley, 1978
Jahr Quelle:2020
Band/Heft Quelle:43(2020), 3, Seite 602-610
ISSN Quelle:1573-2665
Abstract:Aromatic l-amino-acid decarboxylase (AADC) deficiency is an inherited disorder of biogenic amine metabolism with a broad neurological phenotype. The clinical symptoms overlap with other diseases resulting in an often delayed diagnosis. Innovative disease-changing treatment options, particularly gene therapy, have emphasised the need for an early diagnosis. We describe the first method for 3-O-methyldopa (3-OMD) analysis in dried blood spots (DBS) suitable for high throughput newborn screening (NBS). We established a novel tandem mass spectrometry method to quantify 3-OMD in DBS and successfully tested it in 38 888 unaffected newborns, 14 heterozygous DDC variant carriers, seven known AADC deficient patients, and 1079 healthy control subjects. 3-OMD concentrations in 38 888 healthy newborns revealed a mean of 1.16 μmol/L (SD = 0.31, range 0.31-4.6 μmol/L). 1079 non-AADC control subjects (0-18 years) showed a mean 3-OMD concentration of 0.78 μmol/L (SD = 1.75, range 0.24-2.36 μmol/L) with a negative correlation with age. Inter- and intra-assay variability was low, and 3-OMD was stable over 32 days under different storage conditions. We identified seven confirmed AADC deficient patients (mean 3-OMD 9.88 μmol/L [SD = 13.42, range 1.82-36.93 μmol/L]). The highest concentration of 3-OMD was found in a NBS filter card of a confirmed AADC deficient patient with a mean 3-OMD of 35.95 μmol/L. 14 DDC variant carriers showed normal 3-OMD concentrations. We demonstrate a novel high-throughput method to measure 3-OMD in DBS, which allows integration in existing NBS programs enabling early diagnosis of AADC deficiency.
DOI:doi:10.1002/jimd.12208
URL:kostenfrei: Volltext ; Verlag: https://doi.org/10.1002/jimd.12208
 kostenfrei: Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.12208
 DOI: https://doi.org/10.1002/jimd.12208
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:3-O-methyldopa
 AADC deficiency
 dried blood spot
 newborn screening
 tandem mass spectrometry
K10plus-PPN:1699766436
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68583843   QR-Code
zum Seitenanfang